Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUS) saw a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 1,850,000 shares, a drop of 9.3% from the September 30th total of 2,040,000 shares. Based on an average daily trading volume, of 198,900 shares, the days-to-cover ratio is presently 9.3 days. Approximately 10.0% of the company’s stock are short sold.

Cibus Trading Up 4.0 %

Shares of CBUS traded up $0.16 during midday trading on Friday, hitting $4.15. 49,230 shares of the company’s stock traded hands, compared to its average volume of 134,574. The stock has a market capitalization of $95.82 million, a price-to-earnings ratio of -0.24 and a beta of 1.81. Cibus has a 1 year low of $2.86 and a 1 year high of $23.18. The firm’s fifty day moving average is $4.39 and its 200-day moving average is $9.31.

Cibus (NASDAQ:CBUS) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share for the quarter, missing the consensus estimate of ($0.81) by ($0.33). Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. The business had revenue of $0.84 million during the quarter, compared to analyst estimates of $0.44 million. During the same period in the prior year, the business posted ($3.05) EPS. On average, equities research analysts anticipate that Cibus will post -3.84 EPS for the current year.

Analyst Ratings Changes

Several analysts have issued reports on CBUS shares. Canaccord Genuity Group reaffirmed a “buy” rating and set a $20.00 target price on shares of Cibus in a research report on Tuesday, October 22nd. Alliance Global Partners decreased their price objective on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research note on Tuesday, September 24th. Finally, Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a research note on Friday, July 19th.

Institutional Investors Weigh In On Cibus

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in Cibus by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock worth $16,215,000 after acquiring an additional 26,017 shares during the last quarter. Armistice Capital LLC purchased a new position in shares of Cibus in the second quarter worth about $5,083,000. Bank of New York Mellon Corp purchased a new stake in Cibus in the second quarter valued at approximately $529,000. Old West Investment Management LLC increased its holdings in Cibus by 3.6% in the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock worth $524,000 after buying an additional 1,868 shares during the period. Finally, Rhumbline Advisers purchased a new position in Cibus during the 2nd quarter worth approximately $221,000. 33.81% of the stock is owned by hedge funds and other institutional investors.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.